Should you buy a closing pharmacy's NHS contract?

Can you buy just the NHS contract?

No. There is no such thing as a free-standing NHS pharmacy contract. What a pharmacy holds is an entry on NHS England's pharmaceutical list for named premises. The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 decide how that entry can pass to someone else. The listing follows the business at the premises. It does not follow the seller, the fixtures or the patient list.

That is the first thing to understand about a distressed purchase. The seller may be desperate to sell "the contract" and keep the shop, or to sell it to you so you can run it from your own premises a mile away. Neither is available. What is available is set out in Part 4 of the Regulations under the heading "excepted applications", and it comes down to two routes.

Which routes do the 2013 Regulations allow?

Change of ownership under regulation 26, or consolidation under regulation 26A. A third route, applying afresh once the pharmacy has closed, is a routine application judged against the pharmaceutical needs assessment and is covered at the end. The table sets out how they compare.

Two routes that used to exist have narrowed. A distance selling listing cannot be taken over by a change-of-ownership application unless it would still meet the distance selling conditions in regulation 25(2). And since 23 June 2025 the Regulations no longer allow applications for new distance selling premises at all. The transitional provision in regulation 25A covers only applications made before that date. An existing distance selling listing can therefore be bought, but not created.

How long is the window before the listing dies?

Usually three months, and that is your deadline. Regulation 67 requires an owner who intends to close voluntarily to tell NHS England at least three months before the date services stop. For premises with a 100-hour condition the period is six months. NHS England may agree a shorter period. Once services stop on that date, regulation 75 requires NHS England to remove the listing, or to remove the contractor from the list entirely if it has no other premises.

A closure that is not planned is caught by regulation 74. Where a pharmacy has provided no services at listed premises for six months, NHS England must remove the listing, after giving notice and 30 days for representations. The same regulation removes a contractor who has died or ceased to carry on the business, with one exception. When a sole trader dies, the listing continues while a representative under the Medicines Act 1968 carries on the business within the period that Act allows. That is the situation in which an executor may sell a pharmacy that is still trading.

Administration has its own rule. Since 9 November 2020, regulation 67A requires an NHS chemist that enters administration to notify NHS England. The administrator can still sell the business as a going concern, and the buyer still needs a change-of-ownership application. Jhoots, a chain of more than 100 pharmacies that had bought about 60 branches from LloydsPharmacy in 2023, went into administration at the end of 2025. Its branches passed to Allied Pharmacies. Our closures analysis shows where the next opportunities are likely to appear.

How does a change-of-ownership application work?

You apply to NHS England, through Primary Care Support England, to be included in the pharmaceutical list for the seller's premises, and the seller confirms the sale. PCSE runs the pharmacy market administration service for England, covering market entry, exit and consolidation applications. The application is "excepted", which means it is not tested against the pharmaceutical needs assessment. It is tested instead against the conditions in regulation 26: same premises, same business, same services, no interruption.

Three other approvals run alongside it. The premises must be registered with the GPhC in the name of the new owner under the Medicines Act 1968; the registration does not pass with the sale. Our guide to the GPhC premises application explains the timing. A body corporate must have a superintendent pharmacist in place before it can register; see how to appoint one. And the lease must be assigned or renewed, which needs the landlord, who in a distressed sale may be owed money.

The regulation 26 requirement that services continue is the one buyers underestimate. If the pharmacy closes for a fortnight between exchange and completion, NHS England can treat the interruption as breaking the chain unless it has allowed the gap for good cause. Agree the handover date with NHS England in advance, and plan the responsible pharmacist cover for the day of transfer.

When is consolidation the better route?

When you already own a pharmacy in the same health and wellbeing board area and the bought site adds items you can dispense from your own dispensary. Regulation 26A, inserted on 5 December 2016, lets one contractor consolidate two listed premises onto one. Where the two sites have different owners, the application includes a change of ownership, so the seller's consent is needed. Neither site may be distance selling premises or an LPS pharmacy.

The test is the gap. NHS England asks the health and wellbeing board whether closing the second site would leave a gap in pharmaceutical services that a routine application could fill. If it would, NHS England must refuse. Where the board finds no gap, it publishes a supplementary statement to its needs assessment saying so. Regulation 18(2)(g) then directs NHS England to take account of that statement when it considers an unforeseen benefits application, and the PSNC briefing on regulation 26A says such applications are refused. The briefing describes this as a four-part lock, which lasts until the next pharmaceutical needs assessment is issued. NHS England has four months to decide, and the approval must be acted on within six months.

The commercial logic is simple. You pay for a listing and its items, close a site whose rent, rates and staffing you no longer need, and dispense the volume through fixed costs you already carry. Every item earns the single activity fee, £1.46 since 1 April 2025, without a second dispensary. The risk is patient leakage: a share of the closed site's patients will nominate the nearest competitor instead. Our analysis of who is buying pharmacies shows that scale buyers make exactly this calculation.

What diligence matters when the seller is distressed?

The diligence that explains why it failed. A pharmacy in trouble has usually been in trouble for two or three years, and the records show it if you know where to look. Christie & Co reported that sales with some form of distress rose from 3% of its transactions in 2022 to 10% by the end of 2023. The independent economic analysis for NHS England found 47% of branches were loss-making at EBITDA level in 2023/24. Distress is now ordinary. The table lists what to check and why.

Then ask the question that decides the deal: would the location work with your costs and your services? If the answer depends on the seller's problems disappearing, walk away. If it depends on the site and the listing, which survive the seller, keep going.

Do the staff transfer with the pharmacy?

Yes, in a going-concern sale, and with their existing terms. Regulation 4 of the Transfer of Undertakings (Protection of Employment) Regulations 2006 transfers the contracts of employees assigned to the business to the buyer. Regulation 7 makes a dismissal because of the transfer automatically unfair unless there is an economic, technical or organisational reason entailing changes in the workforce. Regulation 13 requires the seller and buyer to inform and consult employee representatives before the transfer.

Insolvency changes the picture in two ways. Where the seller is in bankruptcy or analogous proceedings instituted with a view to liquidating its assets, regulation 8(7) disapplies regulations 4 and 7, so the staff do not transfer automatically. Where the proceedings are not aimed at liquidation, which is the usual position in an administration, the staff do transfer. But under regulation 8(5) liability for certain statutory arrears does not pass to the buyer and is met from the National Insurance Fund. Regulation 9 also allows agreed variations to terms in those proceedings. Take advice on which side of that line the seller sits before you price the payroll.

For a pharmacy the payroll is the operation. The pharmacist may be the owner, who is leaving. The technicians and dispensers know the patients, the care homes and the PMR. A buyer who intends to consolidate and close the site should plan the redundancies and their cost from the start. Regulation 7 will not let them be dressed up as anything else.

What should you pay for?

The listing and the location, not the operation. A distressed seller's accounts describe a business you are not going to run. What you are buying is the right to dispense NHS prescriptions from that address, the patients who nominate it, and whatever the premises are worth to you. Our valuation guide explains why this site publishes no multiples; the same logic applies with more force to a distressed sale, where the earnings to multiply may be negative.

Price the risks you have identified. Arrears you must clear to keep the wholesaler account and the lease are part of the price. Redundancy costs under a consolidation are part of the price. Stock is at valuation on the day, not on the seller's last stocktake. And the deadline is part of the price. If the closure notice leaves no time for your lender's valuation, either the seller extends it with NHS England's agreement or the deal is a cash deal.

The seller's side of this is set out in our guide to preparing a pharmacy for sale. Read it as a buyer: everything a well-prepared seller would have done, a distressed seller has not, and each gap is either a discount or a reason to stop.

Can a closed contract be reopened?

No. Once the listing has been removed under regulation 74 or 75, there is nothing to transfer. A pharmacy at the same address would need a routine application under Part 3 of the Regulations, judged against the health and wellbeing board's pharmaceutical needs assessment. If the closure has created a need that the assessment does not yet record, an unforeseen benefits application under regulation 18 is possible. NHS England must then weigh whether granting it would harm proper planning, and whether other applicants should be considered at the same time.

Two provisions close doors that look open. After a consolidation, the supplementary statement that no gap was created blocks applications that rely on the gap until the next needs assessment is published. And the "right of return" in regulation 28 is not a general right to reclaim a lost listing. It applies only to former providers of local pharmaceutical services who were given that right when they left the list.

So the answer to the question in the title is a timing answer. A closing pharmacy's contract is worth buying only while it is still a contract, which means before the notice date and before the six-month cessation rule bites. Inside that window the Regulations give you two clean routes. Outside it, you are starting from scratch, and that is a different decision.

Key takeaways

FAQs